CPAP continues to be the treatment of choice for moderate to severe cases of obstructive sleep apnea (OSA).
Many people encounter difficulties with CPAP therapy, and this is supported in the literature with compliance rates quoted at around 50-60%.
This may come as no surprise as users report nasal congestion, dry mouth, sore lips, air blowing into the eyes and claustrophobic sensations So, the treatment of obstructive sleep apnea remains a challenge for health care providers and patients alike.
Also, from a corporate perspective, this challenge represents a huge gap in the market.
An innovation from Ventus Medical is ready to meet this challenge and is set to change the treatment of obstructive sleep apnea.
The aim was to bridge the gap between CPAP and a clinically proven device that the user (and user's partner) can hardly notice.
The Provent TM device utilizes the user's own breathing to create pressure that keeps the user's airway open, thus treating obstructive sleep apnea.
And it is only about the size of a quarter.
An entirely new, innovative mechanism was needed to replace the cumbersome CPAP therapy, but to fit within the confines of the nostrils.
Designers likened this to being asked to reduce all the equipment of a scuba diver to just a nose clip.
This included eliminating the need for a power source and air blower.
The device works by placement just inside the nostrils where expiratory flow is directed through selected pathways.
This results in increased intranasal pressure, similar to the expiratory portion of the breathing cycle during CPAP therapy.
The Provent TM Professional Sleep Apnea Therapy device has been authorized by the FDA for the treatment of obstructive sleep apnea (OSA).
Many people encounter difficulties with CPAP therapy, and this is supported in the literature with compliance rates quoted at around 50-60%.
This may come as no surprise as users report nasal congestion, dry mouth, sore lips, air blowing into the eyes and claustrophobic sensations So, the treatment of obstructive sleep apnea remains a challenge for health care providers and patients alike.
Also, from a corporate perspective, this challenge represents a huge gap in the market.
An innovation from Ventus Medical is ready to meet this challenge and is set to change the treatment of obstructive sleep apnea.
The aim was to bridge the gap between CPAP and a clinically proven device that the user (and user's partner) can hardly notice.
The Provent TM device utilizes the user's own breathing to create pressure that keeps the user's airway open, thus treating obstructive sleep apnea.
And it is only about the size of a quarter.
An entirely new, innovative mechanism was needed to replace the cumbersome CPAP therapy, but to fit within the confines of the nostrils.
Designers likened this to being asked to reduce all the equipment of a scuba diver to just a nose clip.
This included eliminating the need for a power source and air blower.
The device works by placement just inside the nostrils where expiratory flow is directed through selected pathways.
This results in increased intranasal pressure, similar to the expiratory portion of the breathing cycle during CPAP therapy.
The Provent TM Professional Sleep Apnea Therapy device has been authorized by the FDA for the treatment of obstructive sleep apnea (OSA).